![]() | License: Creative Commons Attribution 4.0 PDF - Published Version (838kB) |
- URN to cite this document:
- urn:nbn:de:bvb:355-epub-543424
- DOI to cite this document:
- 10.5283/epub.54342
Abstract
Despite new therapeutic approaches, ovarian cancer is still the most lethal gynecological cancer that is mainly diagnosed in its advanced stages. Contrarily, endometrial cancer is often detected in its early stages. However, in the cases of recurrence or advanced disease, treatment options are still limited. Both the ovary and endometrium are affected by estrogens and their receptors. The ...

Owner only: item control page